He was afebrile and had skin lesions consistent with varicella infection. Respiratory rate was 25/min; there were widespread inspiratory crackles in the chest; and chest radiography (CXR) showed extensive nodular bilateral consolidation throughout both lung fields ( Figure 1 ). On 28% oxygen his arterial PaO2 was 5.4kPa and his PaCO2 5.4kPa. The inspired oxygen concentration was increased to 60% and he was treated with aciclovir 10mg/kg and cefotaxime 2 g, both three times daily. He became increasingly hypoxic over the next 24 hours and was ji Figure 1 Chest radiograph on admission, case 1 Department of Anaesthetics and Intensive Care, Aberdeen Royal Infirmary, Aberdeen AB9 2ZB, UK Correspondence to: Dr John Hunter transferred to the intensive care unit for mechanical ventilation. Despite ventilation with 100% oxygen and a positive end expiratory pressure of 20 cmH2O he remained hypoxic. Peak airway pressures in excess of 35 cmH2O were required *to achieve adequate ventilation. In an attempt to improve oxygenation, inhaled nitric oxide (NO) therapy was started at 10ppm, with an immediate increase in his PaO2. His oxygen requirement gradually lessened over the next 48 hours and NO was slowly discontinued.
On day 15 there was a sudden deterioration in his gas exchange and CXR revealed a large right-sided pneumothorax. This was drained but he eventually required bilateral basal and apical drains for recurrent pneumothoraces. CXR at this stage showed extensive areas of bullous disease.
After slow improvement he was eventually transferred to the medical ward where he spent several weeks convalescing. 4 days after discharge he was readmitted with severe dyspnoea and hypoxaemia due to a further right-sided pneumothorax, which was drained. Computed tomography of the chest revealed numerous loculated pneumothoraces, which were aspirated under local anaesthesia with some improvement in his exercise tolerance. The patient's PaO2, just before discharge and breathing air, was 7.8 kPa and PaCO2 was 5.3 kPa. Forced expiratory volume in 1 s was 0.9 L, forced vital capacity 1.2 L and peak expiratory flow rate 300 L/min (predicted 4.4, 5.4 and 614). During a six-minute walk test he managed only 84 m during which his peripheral oxygen saturation fell from 93% to 83%. He was discharged on home oxygen, which he used almost continuously. However, six months later he had stopped using oxygen at home and pulmonary function tests were as follows: FEV1 1.3, FVC 1.6 and PEFR 360. On a six-minute walk test oxygen saturation was maintained above 90%.
Case 2
A previously well 24-year-old man was admitted to the infection unit with a rash typical of chickenpox and shortness of breath. He was a non-smoker and there was nothing to suggest that he was immunocompromised. He was febrile (39.20C), tachypnoeic, restless and confused.
Bilateral basal crackles were heard in the chest. Blood gases on 28% oxygen were PaO2 10.8 kPa, PaCO2 4.3 kPa. He was treated with parenteral aciclovir, together with benzylpenicillin and flucloxacillin because of secondary skin infection. Although he was not obviously jaundiced on admission his liver function tests were grossly deranged. CXR revealed diffuse bilateral pulmonary consolidation consistent with pneumonitis. His condition deteriorated rapidly and just before transfer to the intensive therapy unit P02 was only 4.8 kPa on 60% oxygen. He was intubated pressures. His oxygen requirements declined rapidly. CXR at discharge showed only some shadowing. Pulmonary function tests a year after the acute illness were entirely normal. COMMENT Pneumonitis, the principal cause of death after varicella infection1, is most likely to develop in the immunocompromised, although the incidence in otherwise healthy adults has been reported as ranging from 10 to 50%2. Pregnant women are at increased risk3. The clinical manifestations appear within a week after the onset of rash, with cough, tachypnoea, chest pain and haemoptysis. At necropsy, the lungs are firm, heavy and plum-coloured with scattered haemorrhagic foci in a distribution resembling the poxlike lesions of the skin. Early interstitial fibrosis has also been reported4. The chest X-ray typically shows diffuse bilateral nodular shadowing. As the disease progresses, the nodules enlarge and coalesce. For treatment, aciclovir is widely recommended. It reduces fever and tachypnoea when started early5, though no trials exist to show that it improves outcome. Its most serious adverse effect, renal dysfunction, can be avoided with adequate hydration.
There is very limited information on the long-term pulmonary sequelae of severe varicella pneumonitis. Patient 2 made a full and uneventful recovery while patient I was left with severe residual lung damage. While he no doubt had more extensive pulmonary involvement, his lung damage was probably also exacerbated by the high inflation pressures required for adequate gas exchange. There has been a vogue for ventilatory strategies that reduce pulmonary barotrauma: tidal volumes and mean airway pressures are limited while positive and expiratory pressure is increased to a level that restricts small airway closure. This often results in high arterial carbon dioxide levels ('permissive hypercapnia'). While this was attempted in our patient, the development of severe respiratory acidosis restricted its use. Others have reported the successful use of continuous positive airway pressure ventilation with a facemask6; and extracorporeal membrane oxygenation has also been described for refractory hypoxaemia in this condition7. What about NO, which we used in patient 1 to improve oxygenation? This agent produces profound local vasodilatation in ventilated regions of the lung and reverses the pulmonary vasoconstriction due to hypoxaemia and other vasoconstrictor stimuli. Although it improves oxygenation in about 70% of patients with acute lung injury, there is at present no evidence that it improves outcome. and mechanical ventilation was achieved with low airway Serotonin syndrome with fluoxetine plus tramadol The serotonin syndrome is a rare but potentially fatal reaction to the combination of a serotonergic agent and a selective serotonin reuptake inhibitor (SSRI) antidepres-sant1. It arises most often when a monoamine oxidase inhibitor is given with an SSRI2. Tramadol is an analgesic commonly used in patients with chronic pain, who are often receiving an SSRI as well. Tramadol inhibits the reuptake of serotonin and the serotonin syndrome has been reported when it was given with the SSRIs paroxetine and sertraline3'4. We report a case with fluoxetine.
CASE HISTORY
A woman aged 31 attended casualty with a ten-day history of involuntary tremor of her right hand which had progressively deteriorated and spread to her face. She had a right-sided headache. Her medical history included fibromyalgia, for which she had taken fluoxetine 20mg daily for three years, and endometriosis. Four weeks earlier she had started taking tramadol 50mg four times a day for abdominal pains related to endometriosis, and after two weeks her general practitioner had increased the dose to 100mg four times daily. There was no family history of note.
On examination she was conscious and oriented but greatly agitated and distressed. There was marked twitching of her face with blepharospasm, and she had a slow 2 Hz tremor of her right arm. She was pyrexial (37.9°C) and sweating. Her cranial nerves were normal and no cerebellar or long tract signs were present. There was some difficulty in articulation, with stuttering speech due to facial twitching.
The symptoms fluctuated, and exacerbations were marked by great anxiety and vigorous almost hysterical movements. On admission, contrast computed tomography of the head and cerebrospinal fluid examination were normal, as were the results of routine haematological and biochemical tests. Serum prolactin was greatly raised (>4500mU/L). She was given procyclidine, clonazepam and diazepam but these had little effect. On the supposition that the movement disorder was drug-induced, the fluoxetine and tramadol were discontinued. The twitching persisted but began to lessen seven days after admission. She was subsequently discharged home. At no stage during her illness was a neuroleptic given. In the outpatient clinic three weeks later she reported occasional stutters and tremors but was much better; serum prolactin was within the normal range (228 mU/L). Two months later she had fully recovered. COMMENT The serotonin syndrome can be difficult to diagnose since the features are non-specific and can be mimicked by various neurological, metabolic and toxicological states. In our patient even a hysterical reaction was considered. Suggested diagnostic criteria include the presence of at least three of the following features: agitation, tremor, mental state changes (e.g. confusion, hypomania), myoclonus, hyperreflexia, fever, shivering, diarrhoea, diaphoresis, and incoordination.1 Our patient exhibited agitation, tremor, fever and shivering. Infections, metabolic causes, and substance abuse or withdrawal should be excluded and the criteria specify that a neuroleptic should not have been started or increased in dosage before the onset of symptoms.
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